Down syndrome maternal serum markers in oocyte donation and other assisted reproductive technologies

Bonnin, Aurore; Müller, Françoise; Sénat, Marie-Victoire; Sault, Corinne; Galland, Armelle; Taieb, Julien; Dreux, Sophie; Bouyer, Jean; Benachi, Alexandra

doi:10.1002/pd.5157

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Down syndrome maternal serum markers in oocyte donation and other assisted reproductive technologies

Abstract: Maternal serum markers for DS screening are significantly modified in ART and OD pregnancies. Because these markers are also markers for obstetrical complications, the rationale for applying correction factors is questionable.

Cited by 4 publications

References 32 publications

Maternal Serum Screening for Chromosomal Abnormalities and Neural Tube Defects

Maternal Serum Screening for Chromosomal Abnormalities and Neural Tube Defects

Levels of angiogenic markers in second-trimester maternal serum from in vitro fertilization pregnancies with oocyte donation

Analyse de l’ADN fœtal dans le sang maternel comme test de dépistage pour la trisomie 21 pour les grossesses gémellaires

Contact Info

Product

Resources

About